{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-21-000043","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2021-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.237998+00:00","generated_at":"2026-06-28T17:10:29.816153+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Integra LifeSciences appoints Jan De Witte as President and CEO, succeeding Peter Arduini","bullets":["Jan De Witte to join prior to end of 2021; also appointed to board of directors.","De Witte previously CEO of Barco N.V. and held senior roles at GE Healthcare IT.","Compensation: $850k base salary, 110% target bonus, $2M initial RSU grant, severance provisions.","Peter Arduini steps down as planned to become GE Healthcare CEO; no disagreement with Integra.","De Witte brings 30-year healthcare/tech experience; appointment follows comprehensive CEO search."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-21-000043","json":"https://secwatch.observer/filing/0000917520-21-000043.json","markdown":"https://secwatch.observer/filing/0000917520-21-000043.md","text":"https://secwatch.observer/filing/0000917520-21-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/iart-20211028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T17:10:29.816153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"16cfdee154","claim":"Jan D. De Witte was appointed as Director at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"the Board of Directors of the Company (the “Board”) also appointed Mr. De Witte as a director of the Board effective in connection with the commencement of his employment","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b8b947061c","claim":"Jan D. De Witte was appointed as President and Chief Executive Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.","evidence_excerpt":"On October 28, 2021, Integra LifeSciences Holdings Corporation (the “Company”) announced the appointment of Jan D. De Witte to serve as its President and Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/917520/000091752021000043/0000917520-21-000043-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}